Is fatty liver always benign and should not consequently be treated?

Nonalcoholic fatty liver disease (NAFLD) consists of a broad spectrum of liver lesions ranging from fatty liver (FL), through nonalcoholic steatohepatitis (NASH), up to cirrhosis. The incidence of nonalcoholic fatty liver disease has increased in recent years due to the high rate of obesity in devel...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of physiology and pharmacology : an official journal of the Polish Physiological Society Vol. 64; no. 1; p. 3
Main Authors:	Fierbinteanu-Braticevici, C, Negreanu, L, Tarantino, G
Format:	Journal Article
Language:	English
Published:	Poland 01-02-2013
Subjects:	Animals Disease Progression Fatty Liver - pathology Humans Non-alcoholic Fatty Liver Disease Risk Factors
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Nonalcoholic fatty liver disease (NAFLD) consists of a broad spectrum of liver lesions ranging from fatty liver (FL), through nonalcoholic steatohepatitis (NASH), up to cirrhosis. The incidence of nonalcoholic fatty liver disease has increased in recent years due to the high rate of obesity in developed countries. Although the dogma "simple steatosis - benign prognosis, nonalcoholic steatohepatitis - severe evolution" still stands for many hepatologists, plenty of data underline the unsuspected evolution, i.e., that some patients may progress from fatty liver towards cirrhosis and hepatocellular carcinoma (HCC). NAFLD is the hepatic manifestation of the metabolic syndrome. In certain metabolic circumstances, isolated hepatic steatosis is not necessarily a benign disorder associating cardiovascular risk and evolution towards severe liver diseases including HCC. We tried to shed some light on this problem, taking into account its major health impact and the variegate and sometimes unpredictable evolution of NAFLD.
ISSN:	1899-1505